bortezomib biotech pharma 3.5 mg powder for solution for injection
target healthcare limited - bortezomib - powder for solution for injection - bortezomib
taro-bortezomib powder for solution
taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 3.5mg - bortezomib (bortezomib mannitol boronic ester) 3.5mg - antineoplastic agents
taro-bortezomib powder for solution
taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 2.5mg - bortezomib (bortezomib mannitol boronic ester) 2.5mg - antineoplastic agents
taro-bortezomib powder for solution
taro pharmaceuticals inc - bortezomib (bortezomib mannitol boronic ester) - powder for solution - 1mg - bortezomib (bortezomib mannitol boronic ester) 1mg - antineoplastic agents
bortezomib-aft
aft pharmaceuticals ltd - bortezomib 3.5mg (as a mannitol boronic ester) - powder for injection - 3.5 mg - active: bortezomib 3.5mg (as a mannitol boronic ester) excipient: mannitol - bortezomib-aft, in combination with melphalan and prednisone, is indicated for the treatment of patients with previously untreated multiple myeloma, who are not suitable for high dose chemotherapy. bortezomib-aft, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib-aft is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.
bortezomib waverley 3.5 mg powder for solution for injection
waverley pharma europe limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 3.5 mg powder for solution for injection
aspire pharma limited - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib medac 3.5 mg powder for solution for injection
medac gesellschaft für klinische spezialpräparate mbh - bortezomib - powder for solution for injection - 3.5 milligram(s) - other antineoplastic agents; bortezomib
bortezomib 1 mg powder for solution for injection
european regulatory affairs t/a ivowen - bortezomib - powder for solution for injection - 1 milligram(s) - other antineoplastic agents; bortezomib